NCT04846478 2026-05-12Phase Ia/Ib Talazoparib + Tazemetostat for mCRPCDana-Farber Cancer InstitutePhase 1 Active not recruiting35 enrolled
NCT04821622 2026-04-07Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPCPfizerPhase 3 Active not recruiting599 enrolled